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Abstract
Objective Salivary total protease and chitinase activities were measured by a broad-spectrum fluorescence resonance energy 
transfer approach as predictors of induction and resolution of gingival inflammation in healthy individuals by applying an 
experimental human gingivitis model.
Methods Dental biofilm accumulated (21 days, Induction Phase) by omitting oral hygiene practices followed by a 2-week 
Resolution Phase to restore gingival health in an experimental gingivitis study. Plaque accumulation, as assessed by the 
Turesky Modification of the Quigley-Hein Plaque Index (TQHPI), and gingival inflammation, assessed using the Modified 
Gingival Index (MGI), scores were recorded and unstimulated saliva was collected weekly. Saliva was analysed for total 
protein, albumin, total protease activity and chitinase activity (n = 18).
Results The TQHPI and MGI scores, as well as total protease activity, increased until day 21. After re-establishment of oral 
hygiene, gingival inflammation levels returned to values similar to baseline (day 0). Levels of protease activity decreased 
significantly, but not to baseline values. Furthermore, ‘fast’ responders, who responded immediately to plaque, exhibited 
significantly higher proteolytic activity throughout the experimental course than ‘slow’ responders, who showed a lagged 
inflammatory response.
Conclusion The results indicate that differential inflammatory responses encompass inherent variations in total salivary 
proteolytic activities, which could be further utilised in contemporary diagnostic, prognostic and treatment modalities for 
periodontal diseases.
Key Points 
Total salivary protease activity was associated with gin-
gival inflammation development among ‘fast’ responders 
in an experimental gingivitis study.
Salivary chitinase did not show any association with 
gingival inflammation scores, irrespective of the gingival 
inflammation development pattern.
Total salivary protease activity could be used to distin-
guish differential gingival inflammatory responses in 
saliva.
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1 Introduction
Periodontal diseases encompass the pathological inflamma-
tory condition of the periodontal tissues, which is initiated 
by oral microbial biofilms. Without elimination of the bio-
films, communities on the tooth surface will proceed towards 
subgingival growth. This leads to direct interactions with 
subgingival epithelium and immune cells, resulting in a 
cascade of inflammatory reactions and in chronic cases to 
destruction of gingival tissue [1]. During periodontal dis-
ease, both bacterial and host-derived proteins are released 
from the point of infection, i.e. the subgingival tissue, into 
the surrounding micro-environment: the gingival crevicular 
fluid (GCF) and saliva. In addition, as a result of bleeding, 
increased amounts of blood proteins, such as serum albumin 
and haemoglobin, are found in these oral fluids as well [2].
As sampling is relatively simple, GCF and saliva are con-
sidered ideal matrices for analysis of compounds involved 
in periodontal infection and inflammation. In this light, 
detailed molecular proteome analysis proved to be mean-
ingful in characterising the comprehensive molecular com-
position of GCF and saliva and confirmed the nature of the 
immunological host response [3–7]. However, the technical 
complexity, time and costs of proteome analysis do not eas-
ily lead to practical applications for clinical chair-site usabil-
ity. In this light and our experience though, enzyme activ-
ity in particular can be helpful to serve as molecular tool 
in bridging periodontal inflammatory processes to clinical 
chair-site practice [8–10]. A large advantage of monitoring 
enzyme activity is that their activity level directly mirrors 
the metabolic state of cells, rather than their presence alone 
[11, 12]. In addition, protease activity can specifically be 
measured by means of specific tailored substrates, monitor-
ing either disappearance of the substrate or appearance of 
the cleavage product [12, 13]. The use of such peptide-based 
substrates enables proteolytic activity in complex matrices, 
and can chemically be adapted to hand-held applications. 
To exemplify, by combining magnetic nanoparticle technol-
ogy with human and bacterial protease substrates, prototype 
chair-site tests have been developed for oral and non-oral 
applications [14–16].
The periodontal protease network, comprising both 
microbiological as well as host proteases, is highly complex 
and involved in a myriad of processes. Yet, the gingipains of 
Porphyromonas gingivalis commonly play a distinctive role 
in this process. Their protein levels are known to account for 
up to 85% of the total periodontal proteasome and are known 
to be involved in a number of processes, including bacterial 
co-aggregation, epithelial adherence through the haemag-
glutinin-adhesion domains and degradation of the extracel-
lular matrix proteins [17–19]. Besides, their activity leads to 
expression of both proinflammatory and anti-inflammatory 
molecules [20–25]. Other well-described examples of 
bacterial proteases of the periodontal proteasome include 
karilysin from Tannerella forsythia and dentisilin from 
Treponema denticola. Karilysin cleaves fibrinogen, elastin 
and fibronectin and is known to inactivate the lectin pathway 
of the complement system by degrading mannose-binding 
lectin, ficolin-2 and ficolin-3. Furthermore, karilysin is able 
to detach tumour necrosis factor (TNF)-α from the surface 
of macrophages [26–28]. Dentilisin is known to be involved 
in circumventing the complement system by cleaving the 
negative regulator factor H [28, 29]. In addition, dentilisin 
degrades human fibrinogen at the inflamed site of periodon-
titis [30]. From the host side, collagenases and the metal-
loproteases (MMPs) are mainly involved during inflamma-
tion. In particular, MMP-1, MMP-3, MMP-8 and MMP-9 are 
found to be upregulated in case of periodontal disease and 
play a role in the regulation of cellular communication and 
immune function involving regulation of peptide hormones, 
cytokines and growth factors [31–37]. Indeed, in a parallel 
study, we recently showed that MMP-8 levels are associated 
with the extent and severity of gingival inflammation [35].
Besides, in previous studies it was reported that salivary 
chitinase levels also change in individuals with periodontal 
diseases. Chitinases, which are secreted by the palatal and 
three major salivary glands, hydrolyse chitin, a typical con-
stituent of the yeast cell wall [31–34, 38, 39]. It was found 
that periodontal treatment for a period of 5 or 6 months 
resulted in a three- to four-fold decrease in chitinase activ-
ity. However, notably, the decrease in chitinase activity upon 
treatment did not correlate with clinical parameters such as 
attachment loss and bleeding on probing; only weak cor-
relations were observed with the changes in probing pocket 
depth and plaque index [33]. Others found that levels of the 
acute-phase chitinase-like protein YKL-40 were found to be 
significantly higher in GCF of patients with gingivitis and 
periodontitis than in healthy controls [40]. Moreover, YKL-
40 levels were found to be higher in patients with chronic 
periodontitis than in patients with gingivitis [41]. Experi-
mental gingivitis studies have been used for evaluations of 
enquiries into gingivitis pathogenesis, as gingival inflamma-
tion is induced by plaque accumulation during abstention of 
oral hygiene, and resolved once oral hygiene is reinstituted. 
While several experimental gingivitis studies have reported 
variations in gingival inflammatory response patterns, few 
attempts have been made to characterise individual variabil-
ity. In the experimental gingivitis study, conducted at Aarhus 
University where these data originate from, two different 
patterns of gingival inflammation response to plaque accu-
mulation were identified and categorised as ‘slow’ and ‘fast’ 
responders [42]. ‘Slow’ responders had lagged inflammation 
response, whereas ‘fast’ responders responded immediately 
to plaque. As the pattern of gingival inflammation develop-
ment is modulated by the host immune response, it is of 
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relevance to investigate the immune components that may 
be associated with a more exacerbated clinical response. 
Accordingly, the aim of the present study was to assess the 
ability of total salivary protease and chitinase activity to 
monitor gingival disease progression and resolution using 
saliva, i.e. total oral fluid samples from the ‘fast’ and ‘slow’ 
responders. More specifically, it was investigated whether 
both total protease and chitinase activity would be discrimi-
native in both groups as an attempt to explain the different 
stages of gingivitis development [42].
2  Materials and Methods
2.1  Design of the Study and Collection of Saliva 
Samples
These analyses include a subset of participants from a larger 
experimental gingivitis study conducted at Aarhus Uni-
versity (Dataset II from Nascimento et al. [42]). Baseline 
characteristics are depicted in Table 1 and Fig. 1 provides a 
flowchart of patient recruitment and participation. This study 
protocol was approved by the Ethical Committee of Central 
Denmark Region (MOUTH: Reference 1-10-72-402-14). 
Before enrolment all participants were given oral and written 
information about the aim and design of the study, duration, 
demands, benefits and possible harm. Participation in this 
study was based on written informed consent. Exclusion cri-
teria comprised use of or need for antibiotics (antibacterials) 
or anti-inflammatories within 6 weeks, systemic conditions 
with known effects on the immune system, probing pocket 
depths > 4  mm, interproximal attachment loss > 2  mm, 
cavitated caries, use of orthodontic appliances, presence of 
crowns or bridgework or inadequate restorations interfer-
ing with plaque control, pregnancy, planned pregnancy or 
breastfeeding, and motoric impairments that hinder effective 
personal oral hygiene [42]. 
The study comprised three phases: (1) a pre-experimen-
tal Oral Hygiene Phase (day − 14 to day 0); (2) an Induc-
tion Phase (day 0–day 21); and (3) a Resolution Phase 
(day 21–day 35). The pre-experimental appointment (day 
− 14 to day 0) comprised clinical examinations, adminis-
tration of questionnaires and measurement of cotinine by 
ELISA (enzyme-linked immunosorbent assay) in saliva to 
verify self-reported smoking status [42]. During the Oral 
Hygiene Phase, a professional prophylaxis (reduction of 
plaque, gingival inflammation and calculus) was performed 
by a dental hygienist. Individuals who achieved bleeding on 
probing < 4% and plaque < 20% were asked to proceed to the 
Induction Phase. Whole unstimulated saliva was collected 
as described previously [4]. At the beginning of the Induc-
tion Phase (day 0), the volunteers were asked to refrain from 
any kind of dental hygiene for 3 weeks. At day 7, 14 and 21 
dental plaque and gingival scores, respectively, were regis-
tered and saliva was collected. After saliva collection and 
clinical examination at day 21, all participants were supplied 
with a new toothbrush and toothpaste in order to re-establish 
self-performed oral hygiene procedures (Resolution Phase). 
At day 35, after saliva collection and clinical examination, 
additional professional cleaning was provided for partici-
pants who required further care to restore gingival health. 
The clinical parameters recorded during the study included 
plaque accumulation, assessed using the Turesky Modifica-
tion of the Quigley-Hein Plaque Index (TQHPI), and gingi-
val inflammation, assessed by the Modified Gingival Index 
(MGI) [43, 44] (Table 1). The saliva samples were aliquoted 
for various aims, frozen down at − 80 °C and stored until 
further use. The saliva samples without protease inhibitors 
(n = 18) were available for further analysis.
2.2  Total Protein Content
Total protein content was measured using a Pierce™ BCA 
Protein Assay Kit (Thermo Scientific, West Palm Beach, 
FL, USA) in 96-well polystyrene microplates (Greiner Bio-
One, Frieckenhausen, Germany), according to the manu-
facturer’s specifications, essentially as described previously 
[7]. Bovine serum albumin (BSA) was used as a standard. 
Optical readouts were obtained using a Multiskan™ FC 
Microplate Photometer (Thermo Scientific) in duplicate.
2.3  Albumin
Polypropylene microplates (Greiner Bio-One) were coated 
with a rabbit polyclonal antibody, anti-(human albumin) 
(Sigma-Aldrich, St Louis, MO, USA), overnight at room 
temperature. Saliva samples were subsequently serially 
diluted two-fold, and incubated for 2 h at 37 °C. Captured 
salivary albumin was detected using horseradish peroxidase 
(HRP)-conjugated rabbit anti-(human albumin) (GeneTex, 
Irvine, CA, USA). Human serum albumin (Sigma-Aldrich) 
was used as a standard.
Table 1  Baseline characteristics of the 18 participants included in all 
three phases of the study
MGI Modified Gingival Index, SD standard deviation, TQHPI 
Turesky Modification of the Quigley-Hein Plaque Index
Baseline characteristics Mean (SD)
Age (years) 25.2 (4.0)
TQHPI score—plaque 0.18 (0.1)
MGI score—gingival inflammation 0.02 (0.0)
Number of teeth 29.1 (1.5)
Daily frequency of toothbrushing 2.8 (0.4)
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2.4  Enzymatic Activities
Black 96-well polypropylene microplates (Greiner Bio-One) 
were used for all fluorescence-based enzymatic activity 
assays. Chitinase activity was quantified by adding 50 μL 
of saliva to a substrate solution of 4-methylumbelliferyl β-d-
N,N0,N00-triacetylchitotrioside (Sigma-Aldrich) to a final 
reaction volume of 200 μL and a substrate concentration 
of 40 nM. The increase in fluorescence was subsequently 
acquired for 15 min at 37 °C [7, 33]. Total protease activity 
was measured based on the cleavage of a broad-spectrum 
fluorescence resonance energy transfer (FRET) substrate, 
designated PEK-054 ([FITC]-NleKKKKVLPIQLNAATDK-
[KDbc]) [45]. Fluorescence was recorded at 2 min intervals 
in a BMG FLUOstar Galaxy microplate reader (MTX Lab 
Systems, Vienna, VA, USA). All enzymatic activity assays 
were performed in duplicate.
2.5  Data Analysis
Mean TQHPI and MGI scores were calculated for each 
individual. Two groups of individuals with different pat-
terns of development in MGI scores during the Induction 
Phase were identified by group-based trajectory modelling 
(GBTM): ‘slow’ and ‘fast’ responders [42]. Accordingly, 
the ‘fast’ responders had higher mean MGI scores at the 
end of the first week of the Induction Phase, in contrast to 
the ‘slow’ responders, who needed an extra week to achieve 
similar mean MGI scores. Levels of protease and chitinase 
activity were log10 transformed due to non-Normal distribu-
tion and skewness. Enzymatic activity and clinical data were 
standardised in order to allow the comparability between 
estimates. Growth curve modelling, executed as multilevel 
mixed-effects regression analysis, was used to analyse the 
effect of time on TQHPI and MGI scores, as well as on sali-
vary protease and chitinase. Such an approach was also used 
to analyse the association between the time-varying salivary 
activity level outcomes (protease and chitinase activity) and 
the clinical covariates (mean MGI, mean TQHPI, mean MGI 
at day − 14). Multilevel analyses were stratified by the pat-
terns of gingival inflammation development. All analyses 
were performed using the software STATA ® version 14.0 
(StataCorp., College Station, TX, USA).
Fig. 1  Flowchart of patient 
recruitment and participa-
tion (see also Dataset II from 
Nascimento et al. [42]). In 
total, saliva samples from 18 
individuals were available for 
analysis from the 42 individuals 
who completed the study
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3  Results
Samples and clinical data from 18 healthy non-smok-
ing volunteers, i.e. 13 females and five males (mean age: 
25.33 ± 4.1 years, range 20–34), with at least 20 teeth were 
used in these analyses. Figure 2 displays the results from the 
growth curve modelling for the effect of time on MGI and 
TQHPI scores over the study period. Overall, both plaque 
and gingival scores increased steadily between day 0 and 
day  21 (p < 0.001). When oral hygiene was restored at 
day 21, both the plaque and gingival scores decreased, 
but the mean TQHPI score did not reach baseline levels at 
day 35 (p < 0.05) (Table 2). In a previous study in this popu-
lation, we were able to identify individuals with different 
gingival development responses to plaque accumulation, 
dubbed ‘fast’ and ‘slow’ responders [42]. While the ‘slow’ 
responders showed a lagged gingival response to plaque 
accumulation, the fast responders seem to respond imme-
diately. Even with a similar TQHPI, ‘fast’ responders had 
higher mean MGI scores, i.e. ~ 1.7 at the end of the first week 
of the Induction Phase, in contrast to the ‘slow’ responders, 
who showed MGI scores of ~ 0.7 and needed an extra week 
to achieve comparable mean MGI scores (p < 0.01).
Total salivary protein content, albumin concentration, 
protease activity and chitinase activity were determined at 
days 0 (baseline), 7, 14, 21 and 35 (Table 3). The distribu-
tions of all biochemical variables showed significant devia-
tions from normal. Compared with baseline, overall protease 
activity was elevated at days 14, 21 and 35 but not at day 7 
(Fig. 3a). At day 35 total protease activity was decreased 
compared with day 21 but did not reach baseline levels 
(Fig. 3a). Chitinase activity at baseline was 152.9 ± 85.6 ΔF/
Δt, but no statistical differences in chitinase activity were 
found at later timepoints (Fig. 3b). Finally, the total pro-
tein content and albumin concentrations at baseline was 
1361 ± 759 and 29.4 ± 11.2 μg/mL, respectively. No statis-
tical differences were found for these two analyses at later 
timepoints (Table 3). 
When investigating the association between the salivary 
markers and gingival inflammation development, results 
revealed that the protease activity increased over time, but 
reached statistical significance only at the end of the 3-week 
Induction Phase (day 21) (Fig. 3a). Stratified analysis based 
on the trajectories of gingival inflammation development 
(‘fast’ and ‘slow’ responders) was performed to investigate 
whether protease and chitinase activity would explain the 
different clinical response between the response groups. 
This analysis revealed that among ‘fast’ responders, the 
Fig. 2  Results from mixed-effects multilevel models. a Mean TQHPI 
score as a function of day of experiment and pattern of gingival 
inflammation response. b Mean MGI score as a function of mean 
TQHPI, day of experiment and pattern of gingival inflammation 
response. Estimates given are the standardised regression coefficients 
(95% confidence interval). MGI modified gingival index, TQHPI 
Turesky Modification of the Quigley-Hein Plaque Index
Table 2  Scoring of the plaque and gingival indices as well as the mean percentage with plaque and gingival index
Different capital letters in a row indicate statistical differences
SD standard deviation
Index Day
0 7 14 21 35
Median plaque index (range) 0.11 (0–0.5)A 1.44 (0.9–2.8)B 2.44 (1.5–3.5)C 3.0 (2.2–4.0)D 0.5 (0.1–1.3)E
Mean plaque index (SD) 0.14 (0.1)A 1.59 (0.5)B 2.52 (0.5)C 3.01 (0.4)D 0.57 (0.3)E
Median gingival index (range) 0.0 (0–0.1)A 0.38 (0.1–1.4)B 1.28 (0.4–2.4)C 1.9 (0.9–2.3)D 0.12 (0–1.3)E
Mean gingival index (SD) 0.01 (0.0)A 0.49 (0.3)B 1.34 (0.4)C 1.85 (0.3)D 0.17 (0.2)E
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protease activity was significantly higher at the end of the 
first week of the Induction Phase (day 7) than at baseline, 
while ‘slow’ responders required an extra week to reach a 
significant increase in protease activity (Table 4). Addi-
tionally, ‘fast’ responders showed higher protease activity 
than ‘slow’ responders throughout the entire study period 
(Table 4). The stratified analysis also revealed that MGI was 
inversely associated with the protease activity among ‘fast’ 
responders. However, the chitinase activity was not associ-
ated with gingival inflammation development, irrespective 
of the response group (Table 5).
4  Discussion
The aim of this study was to assess whether protease or 
chitinase activity could be used to monitor induction and 
resolution of gingivitis. For this, the association between 
total salivary protease activity, which includes both host and 
microbial proteases, and experimentally induced gingival 
inflammation were analysed using a broad-spectrum FRET 
approach. In addition, we assessed the chitinase activity in 
the same samples. Our results demonstrated that total sali-
vary protease activity was associated with gingival inflam-
mation development among ‘fast’ responders, while salivary 
chitinase did not show any association with gingival inflam-
mation scores, irrespective of the gingival inflammation 
development pattern.
In the cohort where these data originate from, it was 
recently found that host MMP-8 levels are associated with 
the extent and severity of gingival inflammation [42]. In 
Table 3  Saliva analysis
Different capital letters in a row indicate statistical differences. The p value was adjusted by the number of comparisons
CI confidence interval, SD standard deviation, ΔF/Δt protease and chitinase activity measured by increase of fluorescence in time
a Number of samples assayed for the respective variable out of the total sample population of 18 participants
Variable Day
0 7 14 21 35
Total protein (μg/mL)
 Mean ± SD (na) 1361 ± 758.6A (18) 1188 ± 557.6A (18) 1208 ± 680.1A (18) 855.1 ± 474.3A (18) 1286 ± 940.6A (15)
 95% CI for the mean 984.4–1738 911.1–1466 869.5–1546 483.5–1227 765–1807
Albumin (μg/mL)
 Mean ± SD (na) 29.4 ± 11.2A (18) 29.5 ± 13.2A (18) 31.8 ± 14.4A (18) 37.8 ± 11.2A (17) 31.8 ± 13.6A (18)
 95% CI for the mean 23.8–34.9 22.9–36 24.7–39 32.1–43.6 25–38.7
Chitinase (ΔF/Δt)
 Mean ± SD (na) 152.9 ± 85.6A (15) 148.1 ± 99.7A (16) 154.2 ± 105.2A (16) 203.4 ± 115.2A (16) 159.8 ± 98.6A (16)
 95% CI for the mean 105.5–200.3 95.0–201.2 98.1–210.3 142.1–264.8 107.3–212.4
Protease (ΔF/Δt)
 Mean ± SD (na) 33.0 ± 32.0A (17) 40.5 ± 32.2A (14) 49.5 ± 34.2B (13) 55.7 ± 29.0C (15) 40.7 ± 39.7B (15)
 95% CI for the mean 16.5–49.4 22–59.1 28.4–69.7 39.7–71.8 18.7–62.7
Fig. 3  Results from mixed-effects multilevel models. a Salivary pro-
tease level and as a function of day of experiment. b Salivary chi-
tinase level as a function of day of experiment. Estimates given are 
the standardised regression coefficients (95% confidence interval). 
Both analyses were adjusted for the standardised protein level
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this study we further analysed total protease activity using 
a generic, fluorogenic protease substrate, the breakdown 
of which represents both total bacterial as well as total 
host protease activity [45]. Due to the fact that no albumin 
increase was detected throughout the investigation, leakage 
of proteases originating from serum could be excluded. In 
line with the clinical scores, i.e. on the plaque and gingi-
val indexes, the protease activity, but not chitinase activity, 
increased until oral hygiene was restored. Proteolytic activity 
decreased between day 21 and day 35, but not to baseline 
levels, similar to the clinical scores. These findings are in 
line with earlier studies which showed that inflammation 
of the gingiva is characterised by protease activity of both 
bacterial and human origin [10, 24, 46–48], and with the ear-
lier study on this expanded cohort that revealed that clinical 
‘fast’ responders, compared with ‘slow’ responders, exhibit 
overall higher MMP-8 levels throughout the experimental 
course [42]. These observations collectively underline that 
differential inflammatory host responses of the periodontal 
tissues encompass variations in proteolytic activities, which 
are reflected in saliva, and strengthens the notion that thera-
peutic strategies on the resolution of inflammatory periodon-
tal disease could also target the pharmacological inhibition 
of the proteolytic activity occurring in the oral milieu.
As mentioned earlier, the proteolytic activity was shown 
to be associated with the ‘fast’ but not with the ‘slow’ gingi-
val response pattern (Table 4). We and others postulate that 
this might be a consequence of so-called priming of oral 
neutrophils, here case of the ‘fast’ responders. Previously, 
three distinct neutrophil subsets were identified: resting neu-
trophils, oral biofilm-primed parainflammatory neutrophils 
and proinflammatory neutrophils. These intermediately acti-
vated parainflammatory populations occur in the healthy oral 
cavity and may quickly shift to a proinflammatory phenotype 
Table 4  Results of mixed-effects linear regression of the clinical outcome ‘protease activity’ as a function of time, mean gingival inflammation 
over time and mean gingival inflammation at day − 14
The coefficient denotes the mean difference of the protease activity outcome given the explanatory variables included in the model. The analysis 
was adjusted by protein level. Values in bold indicate statistical significance compared to baseline (p < 0.05)
CI confidence interval
Explanatory variables Protease activity
Total sample (n = 18) ‘Fast’ responders (n = 7) ‘Slow’ responders (n = 11)
Coefficient (95% CI) p value Coefficient (95% CI) p value Coefficient (95% CI) p value
Time (days) (reference: day 0) < 0.001 0.017 0.020
 + 7 0.52 (0.14–1.17) 1.40 (0.04–2.70) 0.53 (0.00–1.05)
 + 14 1.03 (0.41–2.48) 2.21 (0.28–4.14) 0.92 (0.04–0.21)
 + 21 2.33 (0.54–4.12) 3.50 (1.44–5.54) 1.02 (0.09–1.95)
 + 35 1.35 (0.85–1.87) 1.04 (0.33–1.75) 1.00 (0.46–1.54)
Gingival inflammation − 0.33 (1.11–0.45) 0.391 − 0.73 (− 1.23 to − 0.25) 0.031 − 0.10 (− 0.41 to 0.21) 0.443
Gingival inflammation (day − 14) − 0.05 (0.25–0.16) 0.824 0.04 (− 0.20–0.30) 0.662 0.01 (− 0.33 to 0.35) 0.762
Table 5  Results of mixed-effects linear regression of the clinical outcome ‘chitinase activity’ as a function of time, mean gingival inflammation 
over time and mean gingival inflammation at day − 14
The coefficient denotes the mean difference of the chitinase activity outcome given the explanatory variables included in the model. The analysis 
was adjusted by protein level
CI confidence interval
Explanatory variables Chitinase activity
Total sample (n = 18) ‘Fast’ responders (n = 7) ‘Slow’ responders (n = 11)
Coefficient (95% CI) p value Coefficient (95% CI) p value Coefficient (95% CI) p value
Time (days) (reference: day 0) 0.938 0.663 0.701
 + 7 − 0.27 (− 0.69 to 0.13) − 0.35 (− 1.12 to 0.43) − 0.27 (− 0.78 to 0.23)
 + 14 − 0.31 (− 1.21 to 0.60) − 0.53 (− 1.75 to 0.70) − 0.48 (− 1.64 to 0.67)
 + 21 − 0.17 (− 1.20 to 0.86) 0.02 (− 1.12 to 1.16) − 0.61 (− 2.20 to 0.97)
 + 35 − 0.07 (− 0.76 to 0.61) 0.08 (− 0.52 to 0.68) − 0.27 (− 1.28 to 0.75)
Gingival inflammation 0.10 (− 0.47 to 0.66) 0.974 0.26 (− 0.30 to 0.83) 0.829 0.21 (− 0.65 to 1.08) 0.715
Gingival inflammation (day − 14) − 0.05 (− 0.34 to 0.23) 0.897 − 0.01 (− 0.30 to 0.26) 0.989 − 0.19 (− 1.72 to 1.34) 0.905
674 F. J. Bikker et al.
during a periodontal unstable, i.e. diseased, environment. A 
next, subsequent exposure to the oral biofilm will rapidly 
activate the primed parainflammatory neutrophils to respond 
faster than the resting neutrophils [49–51]. Therefore, it can 
be envisaged that it was as a consequence of the activated 
neutrophils and proteases secreted by the biofilm that an 
increase in the total protease activity was detected. In addi-
tion, activation of human pro-MMPs by bacterial proteases 
from potent periopathogens, such as gingipains and den-
tisilin, will contribute to a magnification in total protease 
activity [52, 53].
One may consider the use of a generic protease substrate 
to be a limitation of the study. Firstly, by using PEK-054 
it is not possible to identify the proteases involved and its 
source, i.e. whether its source is of human or bacterial ori-
gin. PEK-054 lacks specificity as it is hydrolysed by virtually 
all bacterial and human salivary proteases. Hence, to study 
the role of bacteria-specific proteases, and in particular gin-
gipains of P. gingivalis, one might consider using recently 
developed bacteria-specific D-amino acid-containing pro-
tease substrates. While l-amino acids represent the vast 
majority of amino acids found in all natural proteins, the 
presence of d-amino acids is highly specific for bacteria 
[13]. Secondly, in case of periodontal disease, the full pro-
tease network is very complex. A variety of both human 
and bacterial proteases may reciprocally inhibit each other, 
or, in contrast, work synergistically to amplify their effects 
as stated earlier. To exemplify, it is known that bacterial 
proteases act synergistically in inactivating the complement 
system, with dentilisins, gingipains and karilysins all con-
tributing by cleaving various molecules of the complement 
system [48, 54]. Accordingly, the gingipains of P. gingi-
valis are able to stimulate triggering receptor expressed on 
myeloid cells 1 (TREM-1) or membrane-bound MMPs, i.e. 
TNF-α-converting enzyme (TACE), which are considered 
to be amplifiers of the inflammatory response, expressed 
by immune and epithelial cells [21, 55–58]. Alternatively, 
bacterial proteases may manipulate the human-derived 
MMP activity in different ways, e.g. through upregulation 
by cleavage of the pro-MMPs or, in contrast, inactivation 
of metabolic active MMPs [47, 49, 52, 53, 59]. However, 
using PEK-054 quantification of total proteolytic activity 
in saliva is accessible and apparently mirrors the course of 
periodontal inflammation.
In contrast to protease activity levels, chitinase activity 
levels were relatively stable throughout the course of the 
study. Even though chitinase activity appeared highest at 
day 21, no statistical differences were found. Although chi-
tinases have not been studied as extensively as proteases in 
periodontal disease, our findings support the data of stud-
ies pointing towards a lack of correlation between chitinase 
activity and gingivitis [33, 34, 40].
5  Conclusion
Total salivary protease activity, measured by a broad-spec-
trum FRET approach, seems to be a good tool to monitor 
induction and resolution of gingival inflammation in situ. 
Individuals with ‘fast’ gingival inflammation development 
present higher levels of total protease activity, which could 
be used to distinguish differential inflammatory responses.
Compliance with Ethical Standards 
Funding This work was supported by the author’s institutions and by 
the Aarhus University Research Foundation.
Conflict of interest FJB, GGN, KN, AS, GNB, WEK, RL and NB de-
clare no conflicts of interest related to this study.
Ethical approval and informed consent This clinical study was 
approved by the Ethical Committee of Central Denmark Region 
(MOUTH: Reference 1-10-72-402-14). Participation in this study was 
based on informed consent. Before enrolment all participants were 
given oral and written information about the aim and design of the 
study, duration, demands, benefits and possible harm.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution-NonCommercial 4.0 International License 
(http://creativecommons.org/licenses/by-nc/4.0/), which permits any 
noncommercial use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the 
source, provide a link to the Creative Commons license, and indicate 
if changes were made.
References
 1. Schenkein HA. Host responses in maintaining periodon-
tal health and determining periodontal disease. Periodontol. 
2000;2006(40):77–93.
 2. Ebersole JL, Schuster JL, Stevens J, Dawson D 3rd, Kryscio RJ, 
Lin Y, et al. Patterns of salivary analytes provide diagnostic capac-
ity for distinguishing chronic adult periodontitis from health. J 
Clin Immunol. 2013;33:271–9.
 3. Bostanci N, Belibasakis GN. Gingival crevicular fluid and 
its immune mediators in theproteomic era. Periodontol. 
2000;2018(76):68–84.
 4. Bostanci N, Ramberg P, Wahlander A, Grossman J, Jonsson D, 
Barnes VM, et al. Label-free quantitative proteomics reveals dif-
ferentially regulated proteins in experimental gingivitis. J Pro-
teome Res. 2013;12:657–78.
 5. Grant MM. What do’omic technologies have to offer periodontal 
clinical practice in the future? J Periodontal Res. 2012;47:2–14.
 6. Lira-Junior R, Ozturk VO, Emingil G, Bostanci N, Bostrom EA. 
Salivary and serum markers related to innate immunity in general-
ized aggressive periodontitis. J Periodontol. 2017;88:3139–47.
 7. Prodan A, Brand HS, Ligtenberg AJ, Imangaliyev S, Tsivtsivadze 
E, van der Weijden F, et al. Interindividual variation, correlations, 
and sex-related differences in the salivary biochemistry of young 
healthy adults. Eur J Oral Sci. 2015;123:149–57.
 8. Afacan B, Ozturk VO, Emingil G, Kose T, Bostanci N. 
Alarm anti-protease trappin-2 negatively correlates with 
675Salivary Total Protease Activity as Predictor of Induction and Resolution of Gingival Inflammation
proinflammatory cytokines in patients with periodontitis. J Peri-
odontol. 2018;89:58–66.
 9. Bostanci N, Emingil G, Afacan B, Han B, Ilgenli T, Atilla G, et al. 
Tumor necrosis factor-alpha-converting enzyme (TACE) levels in 
periodontal diseases. J Dent Res. 2008;87:273–7.
 10. Kaman WE, Galassi F, de Soet JJ, Bizzarro S, Loos BG, Veerman 
EC, et al. Highly specific protease-based approach for detection 
of Porphyromonas gingivalis in diagnosis of periodontitis. J Clin 
Microbiol. 2012;50:104–12.
 11. Galassi F, Kaman WE, Anssari Moin D, van der Horst J, Wismei-
jer D, Crielaard W, et al. Comparing culture, real-time PCR and 
fluorescence resonance energy transfer technology for detection of 
Porphyromonas gingivalis in patients with or without peri-implant 
infections. J Periodontal Res. 2012;47:616–25.
 12. Kaman WE, Hays JP, Endtz HP, Bikker FJ. Bacterial proteases: 
targets for diagnostics and therapy. Eur J Clin Microbiol Infect 
Dis. 2014;33:1081–7.
 13. Kaman WE, Voskamp-Visser I, de Jongh DM, Endtz HP, van Bel-
kum A, Hays JP, et al. Evaluation of a D-amino-acid-containing 
fluorescence resonance energy transfer peptide library for profil-
ing prokaryotic proteases. Anal Biochem. 2013;441:38–43.
 14. Alhogail S, Suaifan GARY, Bizzarro S, Kaman WE, Bikker FJ, 
Weber K, et al. On site visual detection of Porphyromonas gin-
givalis related periodontitis by using a magnetic-nanobead based 
assay for gingipains protease biomarkers. Microchim Acta. 
2018;185(2):149. https ://doi.org/10.1007/s0060 4-018-2677-x.
 15. Chinnappan R, Al Attas S, Kaman WE, Bikker FJ, Zourob M. 
Development of magnetic nanoparticle based calorimetric assay 
for the detection of bovine mastitis in cow milk. Anal Biochem. 
2017;523:58–64.
 16. Wignarajah S, Suaifan GA, Bizzarro S, Bikker FJ, Kaman WE, 
Zourob M. Colorimetric assay for the detection of typical bio-
markers for periodontitis using a magnetic nanoparticle biosensor. 
Anal Chem. 2015;87:12161–8.
 17. Abe N, Baba A, Takii R, Nakayama K, Kamaguchi A, Shibata Y, 
et al. Roles of Arg- and Lys-gingipains in coaggregation of Por-
phyromonas gingivalis: identification of its responsible molecules 
in translation products of rgpA, kgp, and hagA genes. Biol Chem. 
2004;385:1041–7.
 18. Bengtsson T, Khalaf A, Khalaf H. Secreted gingipains from 
Porphyromonas gingivalis colonies exert potent immunomodu-
latory effects on human gingival fibroblasts. Microbiol Res. 
2015;178:18–26.
 19. Yamada M, Ikegami A, Kuramitsu HK. Synergistic biofilm for-
mation by Treponema denticola and Porphyromonas gingivalis. 
FEMS Microbiol Lett. 2005;250:271–7.
 20. Belibasakis GN, Bostanci N, Reddi D. Regulation of protease-
activated receptor-2 expressionin gingival fibroblasts and Jurkat T 
cells by Porphyromonas gingivalis. Cell Biol Int. 2010;34:287–92.
 21. Bostanci N, Belibasakis GN. Porphyromonas gingivalis: an inva-
sive and evasive opportunistic oral pathogen. FEMS Microbiol 
Lett. 2012;333:1–9.
 22. Furuta N, Takeuchi H, Amano A. Entry of Porphyromonas gingi-
valis outer membrane vesicles into epithelial cells causes cellular 
functional impairment. Infect Immun. 2009;77:4761–70.
 23. O’Brien-Simpson NM, Pathirana RD, Walker GD, Reynolds 
EC. Porphyromonas gingivalis RgpA-Kgp proteinase-adhesin 
complexes penetrate gingival tissue and induce proinflammatory 
cytokines or apoptosis in a concentration-dependent manner. 
Infect Immun. 2009;77:1246–61.
 24. Ruggiero S, Cosgarea R, Potempa J, Potempa B, Eick S, Chiquet 
M. Cleavage of extracellular matrix in periodontitis: gingipains 
differentially affect cell adhesion activities of fibronectin and 
tenascin-C. Biochim Biophys Acta. 2013;1832:517–26.
 25. Stathopoulou PG, Galicia JC, Benakanakere MR, Garcia CA, 
Potempa J, Kinane DF. Porphyromonas gingivalis induce 
apoptosis in human gingival epithelial cells through a gingipain-
dependent mechanism. BMC Microbiol. 2009;9:107.
 26. Bryzek D, Ksiazek M, Bielecka E, Karim AY, Potempa B, 
Staniec D, et al. A pathogenic trace of Tannerella forsythia—
shedding of soluble fully active tumor necrosis factor alpha 
from the macrophage surface by karilysin. Mol Oral Microbiol. 
2014;29:294–306.
 27. Jusko M, Potempa J, Karim AY, Ksiazek M, Riesbeck K, Garred 
P, et al. A metalloproteinase karilysin present in the majority of 
Tannerella forsythia isolates inhibits all pathways of the comple-
ment system. J Immunol. 2012;188:2338–49.
 28. Potempa J, Pike RN. Corruption of innate immunity by bacterial 
proteases. J Innate Immun. 2009;1:70–87.
 29. McDowell JV, Huang B, Fenno JC, Marconi RT. Analysis of a 
unique interaction between the complement regulatory protein 
factor H and the periodontal pathogen Treponema denticola. Infect 
Immun. 2009;77:1417–25.
 30. Bamford CV, Fenno JC, Jenkinson HF, Dymock D. The chymo-
trypsin-like protease complex of Treponema denticola ATCC 
35405 mediates fibrinogen adherence and degradation. Infect 
Immun. 2007;75:4364–72.
 31. Gaetti-Jardim Junior E, Nakano V, Wahasugui TC, Cabral FC, 
Gamba R, Avila-Campos MJ. Occurrence of yeasts, enterococci 
and other enteric bacteria in subgingival biofilm of HIV-positive 
patients with chronic gingivitis and necrotizing periodontitis. Braz 
J Microbiol. 2008;39:257–61.
 32. Sardi JC, Duque C, Mariano FS, Peixoto IT, Hofling JF, Goncalves 
RB. Candida spp. in periodontaldisease: a brief review. J Oral Sci. 
2010;52:177–85.
 33. Van Steijn GJ, Nieuw Amerongen AV, Veerman E, Kasanmoen-
talib S, Overdijk B. Chitinase in whole and glandular human sali-
vas and in whole saliva of patients with periodontal inflammation. 
Eur J Oral Sci. 1999;107:328–37.
 34. Van Steijn GJ, Nieuw Amerongen AV, Veerman EC, Kasanmoen-
talib S, Overdijk B. Effect of periodontal treatment on the activity 
of chitinase in whole saliva of periodontitis patients. J Periodontal 
Res. 2002;37:245–9.
 35. Nascimento GG, Baelum V, Sorsa T, Tervahartiala T, Skottrup 
PD, Lopez R. Salivary levels of MPO, MMP-8 and TIMP-1 are 
associated with gingival inflammation response patterns during 
experimental gingivitis. Cytokine. 2019;115:135–41.
 36. Sorsa T, Gursoy UK, Nwhator S, Hernandez M, Tervahartiala 
T, Leppilahti J, et al. Analysis of matrix metalloproteinases, 
especially MMP-8, in gingival creviculular fluid, mouthrinse 
and saliva for monitoring periodontal diseases. Periodontol. 
2000;2016(70):142–63.
 37. Uitto VJ, Suomalainen K, Sorsa T. Salivary collagenase. Origin, 
characteristics and relationship to periodontal health. J Periodon-
tal Res. 1990;25:135–42.
 38. Mushi MF, Bader O, Taverne-Ghadwal L, Bii C, Gross U, 
Mshana SE. Oral candidiasis among African human immunode-
ficiency virus-infected individuals: 10 years of systematic review 
and meta-analysis from sub-Saharan Africa. J Oral Microbiol. 
2017;9:1317579.
 39. Overdijk B, Van Steijn GJ. Human Serum Contains a chitinase—
identification of an enzyme, formerly described as 4-methylum-
belliferyl-tetra-N-acetylchitotetraoside hydrolase (Mu-Tact Hydro-
lase). Glycobiology. 1994;4:797–803.
 40. Roslind A, Johansen JS. YKL-40: a novel marker shared by 
chronic inflammation and oncogenic transformation. Methods 
Mol Biol. 2009;511:159–84.
 41. Keles ZP, Keles GC, Avci B, Cetinkaya BO, Emingil G. Analysis 
of YKL-40 acute-phase protein and interleukin-6 levels in peri-
odontal disease. J Periodontol. 2014;85:1240–6.
676 F. J. Bikker et al.
 42. Nascimento GG, Danielsen B, Baelum V, Lopez R. Identification 
of inflammatory response patterns in experimental gingivitis stud-
ies. Eur J Oral Sci. 2019;127:33–9.
 43. Lobene RR, Weatherford T, Ross NM, Lamm RA, Menaker L. A 
modified gingival index for use in clinical trials. Clin Prev Dent. 
1896;8:3–6.
 44. Turesky S, Gilmore ND, Glickman I. Reduced plaque forma-
tion by the chloromethyl analogue of victamine C. J Periodontol. 
1970;41:41–3.
 45. Janus MM, Keijser BJ, Bikker FJ, Exterkate RA, Crielaard W, 
Krom BP. In vitro phenotypic differentiation towards commensal 
and pathogenic oral biofilms. Biofouling. 2015;31:503–10.
 46. Miao D, Godavikava V, Qian X, Seshadrinathan S, Kapila YL, 
Fenno JC. Treponema denticola upregulates MMP-2 activation 
in periodontal ligament cells: interplay between epigenetics and 
periodontal infection. Arch Oral Biol. 2014;59:1056–64.
 47. Silva N, Abusleme L, Bravo D, Dutzan N, Garcia-Sesnich J, Ver-
nal R, et al. Host response mechanisms in periodontal diseases. J 
Appl Oral Sci. 2015;23:329–55.
 48. Yoneda M, Hirofuji T, Anan H, Matsumoto A, Hamachi T, 
Nakayama K, et al. Mixed infection of Porphyromonas gingivalis 
and Bacteroides forsythus in a murine abscess model: involve-
ment of gingipains in a synergistic effect. J Periodontal Res. 
2001;36:237–43.
 49. Rijkschroeff P, Jansen ID, van der Weijden FA, Keijser BJ, Loos 
BG, Nicu EA. Oral polymorphonuclear neutrophil characteristics 
in relation to oral health: a cross-sectional, observational clinical 
study. Int J Oral Sci. 2016;8:191–8.
 50. Fine N, Hassanpour S, Borenstein A, Sima C, Oveisi M, Scholey J, 
et al. Distinct oral neutrophil subsets define health and periodontal 
disease states. J Dent Res. 2016;95:931–8.
 51. Fredriksson MI. Effect of priming in subpopulations ofperipheral 
neutrophils from patients with chronic periodontitis. J Periodon-
tol. 2012;83:1192–9.
 52. Sorsa T, Ingman T, Suomalainen K, Haapasalo M, Konttinen 
YT, Lindy O, et al. Identification of proteases from periodon-
topathogenic bacteria as activators of latent human neutrophil 
and fibroblast-type interstitial collagenases. Infect Immun. 
1992;60:4491–5.
 53. Nieminen MT, Listyarifah D, Hagström J, Haglund C, Grenier 
D, Nordström D, et al. Treponema denticola chymotrypsin-like 
proteinase may contribute to orodigestive carcinogenesis through 
immunomodulation. Br J Cancer. 2018;118:428–34.
 54. Potempa M, Potempa J. Protease-dependent mechanisms 
of complement evasion by bacterial pathogens. Biol Chem. 
2012;393:873–88.
 55. Bostanci N, Bao K, Wahlander A, Grossmann J, Thurnheer T, 
Belibasakis GN. Secretome of gingival epithelium in response to 
subgingival biofilms. Mol Oral Microbiol. 2015;30:323–35.
 56. Bostanci N, Thurnheer T, Belibasakis GN. Involvement of the 
TREM-1/DAP12 pathway in the innate immune responses to Por-
phyromonas gingivalis. Mol Immunol. 2011;49:387–94.
 57. Willi M, Belibasakis GN, Bostanci N. Expression and regulation 
of triggering receptor expressed on myeloid cells 1 in periodontal 
diseases. Clin Exp Immunol. 2014;178:190–200.
 58. Bostanci N, Reddi D, Rangarajan M, Curtis MA, Belibasakis GN. 
Porphyromonas gingivalis stimulates TACE production by T cells. 
Oral Microbiol Immunol. 2009;24:146–51.
 59. Jotwani R, Eswaran SVK, Moonga S, Cutler CW. MMP-9/TIMP-1 
imbalance induced in human dendritic cells by Porphyromonas 
gingivalis. Fems Immunol Med Mic. 2010;58:314–21.
